ITN Study: Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes (NIH Grant Administered by Benaroya Research Institute at Virginia Mason) (2018–2020)

Grant type:
Immune Tolerance Network - NIAID/NIH under grant number 5UM1AI109565 - administered by Benaroya Research Institute at Virginia Mason
Researchers:
  • Arthritis Qld Chair of Rheumatology
    The University of Queensland Diamantina Institute
    Faculty of Medicine
Funded by:
Immune Tolerance Network - NIAID/NIH under grant number 5UM1AI109565 - administered by Benaroya Research Institute at Virginia Mason